General Cannabis Corp (CANN)
OTHER OTC:CANN
Want to see CANN full AI Analyst Report?
Top Page
General Cannabis
(OTC:CANN)
Select Model
Select Model
Rating:42Neutral
Price Target:
$0.02
▼(-57.50% Downside)
Action:Upgraded
Date:05/28/26
The score is held down primarily by weak financial quality—negative equity, ongoing losses, and persistently negative operating/free cash flow—despite improving operating performance. Technical signals also remain bearish (below key moving averages with negative MACD), while valuation is difficult to justify with a negative P/E and no dividend support.
Positive Factors
Improving operating profitability
EBIT turning positive in 2025 indicates the core operations can generate operating profit, reflecting improved cost structure or pricing. This durable improvement supports margin sustainability, reduces reliance on non-operating fixes, and strengthens the path to sustained profitability if maintained.
Negative Factors
Negative shareholder equity
Negative equity materially weakens financial flexibility and raises refinancing and solvency risk. It distorts leverage metrics, makes creditors more conservative, and limits ability to fund growth internally. This capital-structure weakness is a persistent constraint on strategic options.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving operating profitability
EBIT turning positive in 2025 indicates the core operations can generate operating profit, reflecting improved cost structure or pricing. This durable improvement supports margin sustainability, reduces reliance on non-operating fixes, and strengthens the path to sustained profitability if maintained.
Read all positive factors
General Cannabis (CANN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$2.01M
Dividend YieldN/A
Average Volume (3M)152.58K
Price to Earnings (P/E)―
Beta (1Y)-0.24
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees91
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding110,934,220
10 Day Avg. Volume152,002
30 Day Avg. Volume152,580
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-0.99
Price to Sales (P/S)0.33
P/FCF Ratio-2.78
Enterprise Value/Market Cap11.66
Enterprise Value/Revenue1.71
Enterprise Value/Gross Profit4.03
Enterprise Value/Ebitda27.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
General Cannabis Business Overview & Revenue Model
Company Description
Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light depr...
How the Company Makes Money
null...
General Cannabis Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
12
Very Negative
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.66M | 11.67M | 13.66M | 18.14M | 13.44M | 5.93M |
| Gross Profit | 5.82M | 5.37M | 5.45M | 6.57M | 4.87M | 1.49M |
| EBITDA | 849.74K | 1.14M | 900.75K | -1.64M | -2.84M | -6.12M |
| Net Income | -4.15M | -842.82K | -3.48M | -7.08M | -9.48M | -8.87M |
Balance Sheet | ||||||
| Total Assets | 20.76M | 22.65M | 20.76M | 23.25M | 31.69M | 22.02M |
| Cash, Cash Equivalents and Short-Term Investments | 214.33K | 1.48M | 214.33K | 969.68K | 2.58M | 2.05M |
| Total Debt | 17.31M | 22.79M | 17.31M | 17.88M | 22.54M | 10.15M |
| Total Liabilities | 23.84M | 26.50M | 23.84M | 23.10M | 25.29M | 12.42M |
| Stockholders Equity | -3.07M | -3.93M | -3.07M | 148.16K | 6.41M | 9.61M |
Cash Flow | ||||||
| Free Cash Flow | -704.76K | -1.40M | -704.76K | -1.43M | -2.11M | -2.98M |
| Operating Cash Flow | -654.15K | -1.40M | -654.15K | -1.13M | -2.05M | -2.65M |
| Investing Cash Flow | -50.60K | 55.92K | -50.60K | -304.42K | -1.95M | -978.74K |
| Financing Cash Flow | -50.59K | 2.60M | -50.59K | -184.25K | 4.53M | 4.93M |
General Cannabis Technical Analysis
Negative
0.04
Price Trends
0.03
Negative
0.03
Negative
0.04
Negative
Market Momentum
>-0.01
Positive
38.45
Neutral
80.41
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CANN, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.03, and above the 200-day MA of 0.04, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 38.45 is Neutral, neither overbought nor oversold. The STOCH value of 80.41 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CANN.
General Cannabis Risk Analysis
General Cannabis disclosed 33 risk factors in its most recent earnings report. General Cannabis reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
General Cannabis Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $493.02M | -6.99 | 190.87% | ― | -7.30% | -3.31% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | $36.49M | -0.75 | -122.57% | ― | -100.00% | 54.21% | |
47 Neutral | $7.87M | -2.95 | -40.66% | ― | 2.00% | 94.31% | |
42 Neutral | $1.83M | -14.53 | -93.87% | ― | -6.14% | -24.22% | |
42 Neutral | $2.01M | -2.38 | ― | ― | ― | ― |
* Healthcare Sector Average
CANN
General Cannabis
0.02
>-0.01
-33.33%
YCBD
cbdMD
0.75
-0.23
-23.47%
AQST
Aquestive Therapeutics
3.93
0.75
23.58%
IMCC
IM Cannabis Corp
0.29
-2.59
-89.79%
IXHL
Incannex Healthcare Limited Sponsored ADR
3.05
-2.65
-46.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.